(19)
(11) EP 1 000 060 A1

(12)

(43) Date of publication:
17.05.2000 Bulletin 2000/20

(21) Application number: 98934016.1

(22) Date of filing: 29.06.1998
(51) International Patent Classification (IPC)7: C07D 487/04, C07D 471/04, A61K 31/41, A61K 31/47, A61K 31/505
(86) International application number:
PCT/SE9801/286
(87) International publication number:
WO 9902/528 (21.01.1999 Gazette 1999/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV MK RO SI

(30) Priority: 09.07.1997 SE 9702652
14.10.1997 SE 9703735

(71) Applicant: AstraZeneca UK Limited
London W1Y 6LN (GB)

(72) Inventors:
  • COOKE, Andrew
    Glasgow G74 4RF (GB)
  • BONNERT, Roger
    Leics. LE11 5RH (GB)
  • CAGE, Peter
    Leics. LE11 5RH (GB)
  • DONALD, David
    Leics. LE11 5RH (GB)
  • FURBER, Mark
    Leics. LE11 5RH (GB)
  • WITHNALL, Jane
    Leics. LE11 5RH (GB)

(74) Representative: As Sivborg, Susanne Birgitta et al
Astra AB,Intellectual Property, Patents
151 85 Södertälje
151 85 Södertälje (SE)

   


(54) NOVEL COMPOUNDS